Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

School district leaders plan for H1N1 pandemics using a four-step process

School district leaders planning for H1N1 pandemics should update emergency plans using a four-step process, according to the McGraw-Hill Education Urban Advisory Resource, a team of former educators and school administrators dedicated to serving the unique needs of large school districts.

6 Nov 2009

Unum enhances the wellness benefit of its critical illness products by adding H1N1 vaccine

Unum has enhanced the wellness benefit of its critical illness products by adding the H1N1 vaccine to the list of qualifying procedures.

6 Nov 2009

Average cost of patient deaths much higher than patients who were discharged alive

One of every three people who died in 2007 in the United States were in the hospital for treatment at the time of their deaths, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. The cost of their hospital stays was about $20 billion.

6 Nov 2009

HHS announces contract awards for up to 120,000 treatment courses of intravenous antiviral drugs

The U.S. Department of Health and Human Services (HHS) today announced contract awards for up to 120,000 treatment courses of intravenous (IV) antiviral drugs to help treat hospitalized 2009 H1N1 influenza patients.

6 Nov 2009

GenVec and SAIC-Frederick signs contract to develop influenza and HIV vaccines

GenVec, Inc, announced today that SAIC-Frederick, Inc. has signed a contract with GenVec for the development of influenza and HIV vaccines in support of the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).

5 Nov 2009

U.S. health officials offer no prediction of when all high-risk groups will have access to H1N1 vaccine

U.S. health officials briefing Congress on Wednesday would not outline a timeline for when enough H1N1 (swine flu) vaccines would be available to reach all high-risk populations in the country, the Washington Post reports.

5 Nov 2009

Alliant Health Plans forges alliance with Alliant Sense

Alliant Health Plans, a not-for-profit health plan with a radically new approach focused on patient care, and Global Behavioral Solutions (gBehavior), the industry leader in the utilization of incentive-based behavior modification strategies, have formed an alliance to launch Alliant Sense, a wellness rewards program that motivates members and patients to make healthy life choices.

5 Nov 2009

Five life-saving tips to survive a hospital stay

With the numbers of H1N1 (Swine Flu) cases flooding emergency rooms all over the country, you'll want to do everything you can to prevent contracting H1N1 and being subjected to fatal medical errors and infectious diseases if you have to go into the hospital. Martine Ehrenclou, author of the multiple award winning book, Critical Conditions: The Essential Hospital Guide To Get Your Loved One Out Alive, offers five life-saving tips to stay safe and free of disease if you have to be in the hospital.

5 Nov 2009

Can American ginseng relieve health problems?

With the current outbreak of influenza-like illnesses, many people are trying to boost their immune systems with supplements. Ginseng is often a key ingredient, but its therapeutic use may extend far beyond that. Researchers are now investigating whether ginseng can help relieve health problems ranging from diabetes to depression to erectile dysfunction.

5 Nov 2009

Japanese data suggests a protocol for schools to follow during H1N! pandemic

As flu season approaches, parents around the country are starting to face school closures. But how bad should an influenza outbreak be for a school to shut down? A study led by epidemiologists John Brownstein, PhD, and Anne Gatewood Hoen, PhD of the Children's Hospital Boston Informatics Program, in collaboration Asami Sasaki of the University of Niigata Prefecture (Niigata, Japan), tapped a detailed set of Japanese data to help guide decision making by schools and government agencies.

5 Nov 2009

SafetyTies and SafetyScarves of SafeSmart help reduce the spread of H1N1

According to the Centers for Disease Control (CDC), H1N1 - better known as the swine flu - was widespread in 48 states as of Oct. 18-24. The CDC's website offers guidelines, from cough etiquette to keeping sick workers at home, for healthcare professionals and the public on how to minimize spread of the H1N1 influenza.

5 Nov 2009

Phadia offers ImmunoCAP, a reliable test to accurately diagnose the severity of egg allergy

The World Health Organization recently declared H1N1 swine flu a global pandemic, resulting in the creation of rigorous vaccination programs worldwide. Children are among those considered particularly susceptible to contracting swine flu and are viewed as a top priority in receiving this vaccine.

5 Nov 2009

Poor housing conditions can lead to chronic disease and premature death

Being warm enough at home might lead to better health, according to a new review appearing online in the American Journal of Public Health.

5 Nov 2009

Online self-assessment tool on MayoClinic.com helps assess flu symptoms

The flu symptoms self-assessment tool on MayoClinic.com helps you assess whether you or your loved ones have some form of flu, or just a cold. If you possibly or likely have the flu, you'll also learn whether antiviral medication is an option. And you can check a concise list of high-risk groups who should seek medical attention for the flu.

5 Nov 2009

InterMune seeks FDA marketing approval for pirfenidone

InterMune, Inc. today announced that it has submitted an electronic New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF). Pirfenidone has been granted Orphan Drug and Fast Track designation by the FDA, and also has been granted Orphan Drug status in Europe.

5 Nov 2009

Tetracycline-like compound raises hope for treatment of spinal muscular atrophy

A chemical cousin of the common antibiotic tetracycline might be useful in treating spinal muscular atrophy (SMA), a currently incurable disease that is the leading genetic cause of death in infants. This is the finding of a research collaboration involving Adrian Krainer, Ph.D., of Cold Spring Harbor Laboratory (CSHL) and scientists from Paratek Pharmaceuticals and Rosalind Franklin University of Medicine and Science.

5 Nov 2009

NIAID funds CCHI and IMVC programs to help identify new vaccines for emerging infectious diseases

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded approximately $208 million to two programs that support research to better understand the human immune response to emerging and re-emerging infectious diseases, including those that may be introduced into a community through acts of bioterrorism.

5 Nov 2009

USPTO awards Peregrine Pharmaceuticals patent for anti-viral uses of phosphatidylserine targeting antibodies

Peregrine Pharmaceuticals, Inc. today announced that the U.S. Patent and Trademark Office has issued U.S. Patent Number 7,611,704, which includes broad claims covering anti-viral uses of phosphatidylserine (PS)-targeting antibodies including Peregrine's lead clinical compound, bavituximab. PS is a unique marker exposed on the surface of virally infected cells that can be targeted to treat a broad spectrum of virus infections.

5 Nov 2009

Healthcare unions in Nova Scotia to suspend all collective activities till New Year in response to H1N1 flu

Three of the four major healthcare unions in Nova Scotia have agreed to suspend all collective bargaining activities until at least the New Year. This move is in response to the increased pressures that the H1N1 flu pandemic is placing on the province's health system.

5 Nov 2009

House legislation seeks 5 days of sick leave for workers

In an effort to rein in the spread of the H1N1 Flu, Representative George Miller, the chairman of the House Education and Labor Committee, introduced legislation on Tuesday that would guarantee five paid sick days for workers sent home by their employers with a contagious illness. Mr. Miller, Democrat of California, voiced concern that more than 40 million workers did not have paid sick days and that many workers coming into contact with public — like restaurant or school cafeteria employees — would go to work with H1N1 and spread the virus if they could not afford to stay home.

5 Nov 2009

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

School district leaders plan for H1N1 pandemics using a four-step process

Unum enhances the wellness benefit of its critical illness products by adding H1N1 vaccine

Average cost of patient deaths much higher than patients who were discharged alive

HHS announces contract awards for up to 120,000 treatment courses of intravenous antiviral drugs

GenVec and SAIC-Frederick signs contract to develop influenza and HIV vaccines

U.S. health officials offer no prediction of when all high-risk groups will have access to H1N1 vaccine

Alliant Health Plans forges alliance with Alliant Sense

Five life-saving tips to survive a hospital stay

Can American ginseng relieve health problems?

Japanese data suggests a protocol for schools to follow during H1N! pandemic

SafetyTies and SafetyScarves of SafeSmart help reduce the spread of H1N1

Phadia offers ImmunoCAP, a reliable test to accurately diagnose the severity of egg allergy

Poor housing conditions can lead to chronic disease and premature death

Online self-assessment tool on MayoClinic.com helps assess flu symptoms

InterMune seeks FDA marketing approval for pirfenidone

Tetracycline-like compound raises hope for treatment of spinal muscular atrophy

NIAID funds CCHI and IMVC programs to help identify new vaccines for emerging infectious diseases

USPTO awards Peregrine Pharmaceuticals patent for anti-viral uses of phosphatidylserine targeting antibodies

Healthcare unions in Nova Scotia to suspend all collective activities till New Year in response to H1N1 flu

House legislation seeks 5 days of sick leave for workers

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in